IFN-λ gene polymorphisms as predictive factors in chronic hepatitis C treatment-naive patients without access to protease inhibitors.
about
Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals.A systematic review and meta-analysis of HCV clearance.Association of IFNL3 and IFNL4 polymorphisms with hepatitis C virus infection in a population from southeastern Brazil.Real world experience with pegylated interferon and ribavirin in hepatitis C genotype 1 population with favourable IL28B polymorphism.Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients
P2860
IFN-λ gene polymorphisms as predictive factors in chronic hepatitis C treatment-naive patients without access to protease inhibitors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
IFN-λ gene polymorphisms as pr ...... access to protease inhibitors.
@en
type
label
IFN-λ gene polymorphisms as pr ...... access to protease inhibitors.
@en
prefLabel
IFN-λ gene polymorphisms as pr ...... access to protease inhibitors.
@en
P2860
P356
P1476
IFN-λ gene polymorphisms as pr ...... access to protease inhibitors.
@en
P2093
Daniele Blasquez Olmedo
Samária Ali Cader
P2860
P304
P356
10.1002/JMV.24227
P577
2015-05-12T00:00:00Z